Physician
Saint Agnes Pathology Medical Group
Saint Agnes Pathology Medical Group was paid $563K by Medicaid between Jan 2018 and Dec 2024, across 156 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 18% of everything it billed.
33Billing provider infoSAINT AGNES PATHOLOGY MEDICAL GROUP
FRESNO, CA 93720
FRESNO, CA 93720
33aNPI1700804689assigned 07/18/2006
33bProvider typeClinical Pathology/Laboratory Medicine Physician
28Total paid$563K
24GClaims641,524
24DCodes billed156
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Pathology/Laboratory Medicine Physician providers in California
Rank by total paid#8 of 21
Median peer was paid$69K
This provider vs. median8.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,180 | $41K | |
| 2019 | 24,551 | $22K | |
| 2020 | 20,860 | $21K | |
| 2021 | 63,966 | $36K | |
| 2022 | 90,823 | $97K | |
| 2023 | 164,608 | $177K | |
| 2024incomplete | 247,536 | $169K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 18% | 26,803 | 20,851 | $100K |
| 88307 | 12% | 7,892 | 7,592 | $68K | |
| 80053 | Comprehensive metabolic panel | 12% | 67,872 | 31,960 | $65K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11% | 95,027 | 45,719 | $64K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.1% | 38,254 | 17,879 | $23K |
| 88342 | 3.9% | 7,733 | 7,263 | $22K | |
| 82805 | 3.8% | 5,002 | 2,852 | $21K | |
| 88360 | 3.0% | 1,624 | 1,450 | $17K | |
| 85027 | 2.4% | 29,811 | 16,749 | $14K | |
| 87040 | 2.2% | 9,509 | 7,603 | $12K | |
| 88304 | 2.1% | 5,269 | 5,200 | $12K | |
| 83880 | 2.0% | 5,322 | 4,411 | $11K |
144 more codes
| 87641 | 2.0% | 4,588 | $11K | |
| 84484 | 1.5% | 13,505 | $9K | |
| 88341 | 1.4% | 1,435 | $8K | |
| 83735 | 1.3% | 44,631 | $7K | |
| 83605 | 1.0% | 10,660 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 353 | $6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,672 | $5K |
| 85610 | <1% | 13,019 | $5K | |
| 83690 | <1% | 14,580 | $4K | |
| 80202 | <1% | 3,505 | $4K | |
| 80069 | <1% | 4,595 | $4K | |
| 88108 | <1% | 1,111 | $3K | |
| 87186 | <1% | 5,360 | $3K | |
| 80061 | Lipid panel | <1% | 2,761 | $3K |
| 87070 | <1% | 3,195 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,286 | $3K |
| 84100 | <1% | 25,117 | $3K | |
| 82746 | <1% | 1,744 | $2K | |
| 87077 | <1% | 3,289 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,441 | $2K |
| 81001 | <1% | 12,954 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 929 | $2K |
| 87493 | <1% | 710 | $2K | |
| 83520 | <1% | 2,533 | $2K | |
| 86850 | <1% | 11,242 | $2K | |
| 86901 | <1% | 12,011 | $2K | |
| 86900 | <1% | 11,109 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,074 | $2K |
| 86140 | <1% | 3,656 | $1K | |
| 82330 | <1% | 2,005 | $1K | |
| 83540 | <1% | 2,117 | $1K | |
| 80076 | <1% | 2,733 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 493 | $992.79 |
| 82140 | <1% | 2,835 | $980.37 | |
| 83615 | <1% | 1,847 | $964.05 | |
| 81025 | <1% | 3,268 | $912.94 | |
| 85730 | <1% | 6,258 | $896.15 | |
| 80074 | <1% | 800 | $848.83 | |
| 82728 | <1% | 2,484 | $815.52 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,452 | $789.18 |
| 87340 | <1% | 887 | $760.71 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 156 | $750.00 |
| 82607 | <1% | 1,819 | $743.15 | |
| 83970 | <1% | 154 | $710.44 | |
| 89051 | <1% | 858 | $645.44 | |
| 87147 | <1% | 1,801 | $639.30 | |
| 84466 | <1% | 2,135 | $592.50 | |
| 86780 | <1% | 5,135 | $523.54 | |
| 82248 | <1% | 8,926 | $505.63 | |
| 84132 | <1% | 4,277 | $502.86 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,274 | $500.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 4,239 | $489.08 |
| 87205 | <1% | 2,974 | $487.83 | |
| 88311 | <1% | 738 | $439.33 | |
| 88312 | <1% | 38 | $341.41 | |
| 86703 | <1% | 804 | $330.14 | |
| 82550 | <1% | 2,053 | $326.55 | |
| 82565 | <1% | 661 | $306.10 | |
| 80306 | <1% | 1,680 | $285.00 | |
| 85652 | <1% | 1,336 | $278.00 | |
| 85379 | <1% | 2,388 | $261.08 | |
| 85018 | <1% | 2,623 | $258.03 | |
| 84439 | <1% | 1,763 | $255.52 | |
| 84157 | <1% | 577 | $245.16 | |
| 82945 | <1% | 542 | $240.72 | |
| 86077 | <1% | 163 | $224.39 | |
| 85007 | <1% | 2,642 | $202.64 | |
| 82150 | <1% | 1,036 | $199.35 | |
| 87088 | <1% | 1,759 | $188.30 | |
| 82310 | <1% | 461 | $184.89 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 193 | $179.93 |
| 87075 | <1% | 563 | $178.20 | |
| 86923 | <1% | 120 | $162.01 | |
| 85014 | <1% | 865 | $137.83 | |
| 88302 | <1% | 135 | $137.60 | |
| 82570 | <1% | 1,548 | $131.59 | |
| 84703 | <1% | 6,020 | $128.24 | |
| 87899 | <1% | 231 | $125.65 | |
| 84550 | <1% | 1,363 | $123.61 | |
| 84156 | <1% | 1,554 | $118.16 | |
| 87015 | <1% | 197 | $117.96 | |
| 87045 | <1% | 245 | $115.27 | |
| 85060 | <1% | 81 | $114.96 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 166 | $114.91 |
| 85046 | <1% | 829 | $113.45 | |
| 86141 | <1% | 260 | $110.22 | |
| 80047 | <1% | 503 | $92.83 | |
| 88313 | <1% | 31 | $90.35 | |
| 85384 | <1% | 250 | $83.22 | |
| 84478 | <1% | 962 | $83.21 | |
| 86880 | <1% | 1,576 | $76.46 | |
| 82247 | <1% | 2,420 | $76.43 | |
| 84702 | <1% | 1,921 | $71.53 | |
| 86160 | <1% | 134 | $71.22 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,024 | $68.97 |
| 82272 | <1% | 174 | $62.77 | |
| 84300 | <1% | 467 | $61.73 | |
| 85520 | <1% | 299 | $56.67 | |
| 86376 | <1% | 196 | $56.04 | |
| 86317 | <1% | 92 | $51.26 | |
| 86706 | <1% | 349 | $46.99 | |
| 86592 | <1% | 854 | $43.46 | |
| 83935 | <1% | 152 | $35.74 | |
| 82731 | <1% | 40 | $31.48 | |
| 80051 | <1% | 199 | $29.48 | |
| 85460 | <1% | 270 | $29.09 | |
| 87210 | <1% | 929 | $28.53 | |
| 86870 | <1% | 160 | $24.75 | |
| 87653 | <1% | 36 | $23.12 | |
| 87081 | <1% | 566 | $22.10 | |
| 84480 | <1% | 98 | $22.09 | |
| 81003 | <1% | 621 | $20.01 | |
| 82533 | <1% | 60 | $18.27 | |
| 88300 | <1% | 27 | $16.01 | |
| 86762 | <1% | 269 | $15.97 | |
| 83010 | <1% | 65 | $14.30 | |
| 82043 | <1% | 202 | $12.98 | |
| 86803 | <1% | 104 | $11.93 | |
| 88141 | <1% | 98 | $9.48 | |
| 84133 | <1% | 56 | $9.04 | |
| 83930 | <1% | 58 | $8.22 | |
| 82010 | <1% | 55 | $7.88 | |
| 84155 | <1% | 311 | $7.37 | |
| 87046 | <1% | 182 | $6.68 | |
| 82375 | <1% | 74 | $4.16 | |
| 87116 | <1% | 14 | $3.28 | |
| 84075 | <1% | 21 | $3.07 | |
| 82040 | <1% | 97 | $3.01 | |
| 86308 | <1% | 68 | $2.69 | |
| 84481 | <1% | 40 | $2.63 | |
| 84165 | <1% | 13 | $2.10 | |
| 82810 | <1% | 27 | $1.56 | |
| 82042 | <1% | 14 | $1.53 | |
| 84460 | <1% | 85 | $1.34 | |
| 82950 | <1% | 12 | $0.84 | |
| 82436 | <1% | 14 | $0.59 | |
| 85008 | 0% | 33 | $0.00 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 0% | 247 | $0.00 |
| 86920 | 0% | 12 | $0.00 | |
| 80329 | 0% | 19 | $0.00 | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 0% | 106 | $0.00 |
| 86705 | 0% | 30 | $0.00 | |
| 86709 | 0% | 13 | $0.00 | |
| 82947 | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFANG, WEI (AUTHORIZED OFFICIAL)